Recent advancements in medical technology have revolutionized limb-salvage surgery and functional reconstruction for pediatric bone and soft tissue tumors.
Tevimbra is under clinical development by BeiGene and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase transition success ...
Dostarlimab is under clinical development by GSK and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase transition success ...